Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

New 5' AMP-activated protein kinase activators discovered at Shionogi & Co.

Sep. 8, 2017

Boehringer Ingelheim and Gubra to develop treatments for obesity

Sep. 8, 2017

Lilly presents novel RANKL-targeting fusion proteins

Sep. 7, 2017

Shanghai Institute Materia Medica discovers new AMP-activated protein kinase activators

Sep. 7, 2017

P2Y purinoceptor 6 identified as a target for treating obesity

Sep. 7, 2017

Palatin Technologies enters bremelanotide licensing agreement with Fosun Pharma

Sep. 7, 2017

Crinetics Pharmaceuticals receives two grants from NIDDK

Sep. 7, 2017

JDFR supports development of vTv Therapeutics' TTP-399 for type 1 diabetes

Sep. 7, 2017

AbbVie submits NDA in U.S. for elagolix

Sep. 7, 2017

Janssen discovers prostanoid EP3 receptor antagonists with promising drug characteristics

Sep. 6, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...